Normal cells contain p53 protein in a latent state that can be activat
ed for sequence-specific transcription by low levels of UV radiation w
ithout an increase in protein levels. Microinjection of cells with an
antibody specific to the C-terminal negative regulatory domain can act
ivate the function of p53 as a specific transcription factor in the ab
sence of irradiation damage, suggesting that posttranslational modific
ation of a negative regulatory domain in vivo is a rate-limiting step
for p53 activation. Small peptides derived from the negative regulator
y domain of p53 have been used as biochemical tools to distinguish bet
ween allosteric and steric mechanisms of negative regulation of p53 te
tramer activity. Presented is the development of a highly specific pep
tide activation system that is consistent with an allosteric mechanism
of negative regulation and that forms a precedent for the synthesis o
f novel low molecular mass modifiers of the p53 response.